Down-regulated ECRG4 expression in breast cancer and its correlation with tumor progression and poor prognosis - A short Report
Conclusion
Our data suggest that loss of ECRG4 protein expression may be involved in tumor progression and may serve as a prognostic biomarker for breast cancer.
Source: Cellular Oncology - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Esophagus Cancer | Genetics | Nasopharyngeal Cancer | Study